Detection of the M protein and monoclonal light chains in the blood or urine, lytic bone lesions, renal function dysfunction, hypercalcemia and anemia favors the diagnosis of a MM over PBL (1). This evidence concerns the gene MYOM2 and hypercalcemia disease.